levofloxacin has been researched along with palonosetron in 2 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (palonosetron) | Trials (palonosetron) | Recent Studies (post-2010) (palonosetron) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 469 | 197 | 348 |
Protein | Taxonomy | levofloxacin (IC50) | palonosetron (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0009 | |
5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.003 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.9882 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for levofloxacin and palonosetron
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for levofloxacin and palonosetron
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |